Respiratorius AB (publ)
556552-2652ActiveDeveloping novel drugs to treat aggressive lymphoma cancers.
Biotechnology/Pharmaceutical Companyrespiratorius.com
Oversigt
- Ukendt
- Medarbejdere
- Ukendt
- Omsætning
- 1998
- Grundlagt
Nøglebeslutningstagere
Johan Drott
CEO
@respiratorius.com+46709XXXXXX
Karin Wehlin
Chairman of the Board
@respiratorius.com
Kristina Drott
Board member
@respiratorius.com
Mia Lundblad
Board member
@respiratorius.com
Beskrivelse
Respiratorius AB (publ) is a specialized biotechnology company focused on developing novel drug candidates for treating aggressive cancers. Their primary mission is to reduce the global burden of aggressive lymphoma, particularly Diffuse large B-cell lymphoma (DLBCL). The company bases its drug cand...
BIOINVENT INTERNATIONAL AB